Document is current
Any future updates will be listed below
-
Authors
Cabello Ubeda, Alfonso
Erlandson, Kristine M.
Freeman, Michael L.
Letendre, Scott L.
Wanjalla, Celestine N.
Koethe, John R.
Corley, Michael J.
Hunt, Peter W.
Gianella, Sara
-
Funding
Funding for this research was provided by:
Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
The RIS (Spanish HIV Research Network) Association
National Institute on Aging (NIA K24AG082527)
National Institute on Aging (R01AG082541)
National Institute of Mental Health (P30MH062512, R01MH125720)
National Heart, Lung, and Blood Institute (K23 HL156759)
National Heart, Lung, and Blood Institute (R01HL180319, R01HL152957)
Burroughs Wellcome Fund (1021480)
Doris Duke Charitable Foundation (2021193)
National Institute of Allergy and Infectious Diseases (R01AI155680, K24AI145806)
National Institute of Allergy and Infectious Diseases (AI068636, AI147821, AI155680)
- License Information
-
More Information
Article History
Received: 29 October 2025
Accepted: 29 January 2026
First Online: 20 March 2026
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: Swab with this A.C.U. has served as a consultant and received honoraria from ViiV Healthcare, Gilead Sciences, Johnson & Johnson, and Merck, and has received grants from ViiV Healthcare and Gilead Sciences unrelated to the submitted work. K.M.E. has served as a consultant to ViiV Healthcare, Gilead Sciences, and Merck, and has received study product from Theratechnologies. S.L.L. received funding from Merck in support of a project unrelated to the submitted work. C.N.W. has served as a consultant to and received grant support from Gilead Sciences and Merck & Co. J.R.K. has served as a consultant to and received grant support from Gilead Sciences and Merck & Co. P.W.H. has served as a consultant for Merck and ViiV Healthcare; received research grant support from Gilead Sciences; received drug donation for a clinical trial from Merck; and received honoraria from Gilead Sciences and ViiV Healthcare. S.G., M.L.F., and M.J.C. report no conflicts of interest.
